Inheritance of susceptibility to experimental autoimmune encephalomyelitis

Journal of Neuroscience Research

Volumn 45, Issue 6, 1996, Pages 655-669

  Encinas, J A ^a   Weiner, H L ^a   Kuchroo, V K ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ANIMAL TISSUE; CELLULAR IMMUNITY; ENVIRONMENTAL FACTOR; GENE LOCUS; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; IMMUNIZATION; INBRED STRAIN; INHERITANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT SURVEY;

ANIMALS; CHROMOSOME MAPPING; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOME; MICE; RATS;

EID: 0029785817     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960915)45:6<655::AID-JNR2>3.0.CO;2-7     Document Type: Short Survey

References (85)

1. Acha-Orbea H, Mitchell DJ, Timmermann L, Wraith DC, Tausch GS, Waldor MK, Zamvil SS, McDevitt HO, Steinman L (1988): Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263-273.
2. Al-Sabbagh A, Weiner HL (1994): Rat experimental autoimmune encephalomyelitis. In Cohen IR, Miller A (eds): "Autoimmune Disease Models. A Guidebook." San Diego: Academic Press, pp 15-22.
3. Arnason BG, Jankovic BD, Waksman BH, Wennersten C (1962): Role of the thymus in immune reactions in rats. II. Suppressive effect of thymectomy at birth on reaction of delayed (cellular) hypersensitivity and the circulating small lymphocyte. J Exp Med 116:177-186.
4. Arnon R (1981): Experimental allergic encephalomyelitis - susceptibility and suppression. Immunol Rev 55:5-30.
5. Baker D, Rosenwasser OA, O'Neill JK, Turk JL (1995): Genetic analysis of experimental allergic encephalomyelitis in mice. J Immunol 155:4046-4051.
6. Ben-Nun A, Soffer D (1990): Minor lymphocyte stimulating (Mls) gene products in mice influence their genetic resistance or susceptibility to induction of autoimmune encephalomyelitis. Eur J Immunol 20:195-200.
7. Ben-Nun A, Wekerle H, Cohen IR (1981): The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 11:195-199.
8. Bernard CCA (1976): Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility. J Immunogenet 3:263-274.
9. Blankenhorn EP, Stranford SA, Smith PD, Hickey WF (1991): Genetic differences in the T cell receptor alleles of LEW rats and their encephalomyelitis-resistant derivative, LER, and their impact on the inheritance of EAE resistance. Eur J Immunol 21: 2033-2041.
10. Chung IY, Norris JG, Benveniste EN (1991): Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains. J Exp Med 173:801-811.
11. Copeland NG, Jenkins NA, Gilbert DJ, Eppig JT, Maltais LJ, Miller JC, Dietrich WF, Weaver A, Lincoln SE, Steen RG, Stein LD, Nadeau JH, Lander ES (1993): A genetic linkage map of the mouse: Current applications and future prospects. Science 262: 57-66.
12. Dietrich W, Katz H, Lincoln SE, Shin HS, Friedman J, Dracopoli NC, Lander ES (1992): A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131:423-447.
13. Dietrich WF, Miller JC, Steen RG, Merchant M, Damron D, Nahf R, Gross A, Joyce DC, Wessel M, Dredge RD, Marquis A, Stein LD, Goodman N, Page DC, Lander ES (1994): A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nature Genet 7:220-245.
14. Drake CG, Rozzo SJ, Hirschfeld HF, Smarnworawong NP, Palmer E, Kotzin BL (1995): Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. J Immunol 154:2441-2447.
15. Encinas JA, Lees MB, Sobel RA, Symonowicz C, Greer JM, Shovlin CL, Weiner HL, Seidman CE, Seidman JG, Kuchroo VK (1996): Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. J Immunol 157: In press.
16. Freund J, Stern ER, Pisani TM (1947): Isoallergic encephalomyelitis and radiculitis in guinea pigs after one injection of brain and mycobacteria in water-in-oil emulsion. J Immunol 57:179-194.
17. Fritz RB, McFarlin DE (1989): Encephalitogenic epitopes of myelin basic protein. In Sercarz E (ed): "Antigenic Determinants and Immune Regulation." Basel: Karger, pp 101-125.
18. Fritz RB, Jen Chou C-H, McFarlin DE (1983): Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J X PL/J)F1 mice by myelin basic protein and its peptides: Localization of a second encephalitogenic determinant. J Immunol 130:191-194.
19. Fritz RB, Skeen MJ, Chou CH, Garcia M, Egorov IK (1985): Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. J Immunol 134:2328-2332.
20. Gasser DL, Newlin CM, Palm J, Gonatas NK (1973): Genetic control of susceptibility to experimental allergic encephalomyelitis in rats. Science 181:872-873.
21. Gasser DL, Palm J, Gonatas NK (1975): Genetic control of susceptibility to experimental allergic encephalomyelitis and the Ag-B locus of rats. J Immunol 115:431-433.
22. Gasser DL, Goldner-Sauve A, Hickey WF (1990): Genetic control of resistance to clinical EAE accompanied by histological symptoms. Immunogenetics 31:377-382.
23. Ghosh S, Palmer SM, Rodrigues NR, Cordell HJ, Hearne CM, Cornall RJ, Prins JB, McShane P, Lathrop GM, Peterson LB, Wicker LS, Todd JA (1993): Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nature Genet 4:404-409.
24. Greer JM, Kuchroo VK, Sobel RA, Lees MB (1992): Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J Immunol 149:783-788.
25. Greer JM, Sobel VK, Sette A, Southwood S, Lees MB, Kuchroo VK (1996): Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J Immunol 156:371-379.
26. Gunther E, Odenthal H, Wechsler W (1978): Association between susceptibility to experimental allergic encephalomyelitis and the major histocompatibility system in congenic rat strains. Clin Exp Immunol 32:429-434.
27. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J (1994): The 1993-94 Genethon human genetic linkage map. Nature Genet 7:246-339.
28. Happ MP, Wettstein P, Dietzschold B, Heber-Katz E (1988): Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects. J Immunol 141:1489-1494.
29. Hickey WF, Kirby WM, Teuscher C (1986): BALB/c substrain differences in susceptibility to experimental allergic encephalomyelitis (EAE). Ann NY Acad Sci 475:331-333.
30. Jacob HJ, Pettersson A, Wilson D, Mao Y, Lernmark A, Lander ES (1992): Genetic dissection of autoimmune type I diabetes in the BB rat. Nature Genet 2:56-60.
31. Jansson L, Olsson T, Holmdahl R (1993): Inflence of T-cell receptor genes on chronic experimental autoimmune encephalomyelitis. Immunogenetics 37:466-468.
32. Kallen B, Logdberg L (1982): Experimental autoimmune encephalomyelitis in hybrids between Lewis and Brown Norway rats. Immunobiology 162:86-93.
33. Kallen B, Nilsson O (1986): Dissociation between histological and clinical signs of experimental auto-immune encephalomyelitis. Acta Pathol Microbiol Immunol Scand 94:159-164.
34. Kelero de Rosbo N, Bernard CCA, Simmons RD, Carnegie PR (1985): Concomitant detection of changes in myelin basic protein and permeability of blood-spinal cord barrier in acute experimental autoimmune encephalomyelitis by electroimmunoblotting. J Neuroimmunol 9:349-361.
35. Knobler RL, Linthicum DS, Cohn M (1985): Host genetic regulation of acute MHV-4 viral encephalomyelitis and acute experimental autoimmune encephalomyelitis in (BALB/cKe X SJL/J) recombinant-inbred mice. J Neuroimmunol 8:15-28.
36. Kölsch E, Falkenberg FW (1978): Genetic control of the immne response to phage fd. IV. Complementation between H-2-linked Ir genes. J Immunol 120:2087-2092.
37. Kono DH, Burlingame RW, Owens DG, Kuramochi A, Balderas RS, Balomenos D, Theofilopoulos AN (1994): Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA 91:10168-10172.
38. Kuchroo VK, Martin CA, Greer JM, Ju ST, Sobel RA, Dorf ME (1993): Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 151:4371-4382.
39. Lando Z, Teitelbaum D, Arnon R (1980): Induction of experimental allergic encephalomyelitis in genetically resistant strains of mice. Nature 287:551-552.
40. Lee JM, Olitsky PK (1955): Simple method for enhancing development of acte disseminated encephalomyelitis in mice. Proc Soc Exp Biol Med 89:263-266.
41. Lee JM, Olitsky PK, Schneider HA, Zinder ND (1954): Role of heredity in experimental disseminated encephalomyelitis in mice. Proc Soc Exp Biol Med 85:430-432.
42. Levine S, Saltzman A (1989): The hyperacute form of allergic encephalomyelitis produced in rats without the aid of pertussis vaccine. J Neuropathol Exp Neurol 48:255-262.
43. Levine S, Sowinski R (1973): Experimental allergic encephalomyelitis in inbred and outbred mice. J Immunol 110:139-143.
44. Levine S, Sowinski R (1974): Experimental allergic encephalomyelitis in congenic strains of mice. Immunogenetics 1:352-356.
45. Levine S, Wenk EJ, Devlin HB, Pieroni RE, Levine L (1966): Hyperacute allergic encephalomyelitis: adjuvant effect of pertussis vaccines and extracts. J Immunol 97:363-368.
46. Lindh J, Kallen B (1978): Genetics of susceptibility to experimental autoimmune encephalomyelitis studied in three rat strains. J Immunogenet 5:347-354.
47. Linthicum DS, Frelinger JA (1982): Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes. J Exp Med 155:31-40.
48. Lipton MM, Freund J (1952): Encephalomyelitis in the rat following intracutaneous injection of central nervous system tissue with adjuvant. Proc Soc Exp Biol Med 81:260-261.
49. Lisak RP, Zweiman B, Kies M, Driscoll B (1975): Experimental allergic encephalomyelitis in resistant and susceptible guinea pigs: in vivo and in vitro correlates. J Immunol 114:546-549.
50. Massanari RM, Wilson ML (1983): Differing degrees of susceptibility to experimental allergic encephalomyelitis among inbred strains of hamsters. Clin Immunol Immunopathol 26:370-379.
51. McAleer MA, Reifsnyder P, Palmer SM, Prochazka M, Love JM, Copeman JB, Powell EE, Rodrigues NR, Prins J, Serreze DV, DeLarato NH, Wicker LS, Peterson LB, Schork NJ, Todd JA, Leiter EH (1995): Crosses of NOD mice with the related NON strain. A polygenic model for IDDM. Diabetes 44:1186-1195.
52. McDevitt HO, Chinitz A (1969): Genetic control of antibody response: relationship between immune response and histocompatibility (H-2) type. Science 163:1207-1209.
53. McDevitt HO, Deak BD, Shreffler DC, Klein J, Stimpfling JH, Snell GD (1972): Genetic control of the immune response: Mapping of the Ir-1 locus. J Exp Med 135:1259-1278.
54. Mendel I, Kerlero de Rosbo N, Ben-Nun A (1995): A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: Fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur J Immunol 25:1951-1959.
55. Montgomery IN, Rauch HC (1982): Experimental allergic encephalomyelitis (EAE) in mice: primary control of EAE susceptibility is outside the H-2 complex. J Immunol 128:421-425.
56. Moore MJ, Singer DE, Williams RM (1980): Linkage of severity of experimental allergic encephalomyelitis to the rat major histocompatibility locus. J Immunol 124:1815-1820.
57. Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK (1994): Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1:219-229.
58. Munoz JJ, Mackay IR (1984): Production of experimental allergic encephalomyelitis with the aid of pertussigen in mouse strains considered genetically resistant. J Neuroimmunol 7:91-96.
59. Olitsky PK, Lee JM (1953): Biological properties and variations of reactions of the encephalitogenic agent in nervous tissues. J Immunol 71:419-425.
60. Olitsky PK, Yager RH (1949): Experimental disseminated encephalomyelitis in white mice. J Exp Med 90:213-223.
61. Paterson PY (1960): Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med 111:119-135.
62. Pelfrey CM, Waxman FJ, Whitacre CC (1989): Genetic resistance in experimental autoimmune encephalomyelitis. I. Analysis of the mechanism of LeR resistance using radiation chimeras. Cell Immunol 122:504-516.
63. Pettinelli CB, Fritz RB, Jen Chou C-H, McFarlin DE (1982): Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. J Immunol 129:1209-1211.
64. Raine CS, Barnett LB, Brown A, Behar T, McFarlin DE (1980): Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab Invest 42:150-157.
65. Rivers TM, Sprunt DH, Berry GP (1933): Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 58:39-53.
66. Sakai K, Zamvil SS, Mitchell DJ, Lim M, Rothbard JB, Steinman L (1988): Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J Neuroimmunol 19:21-32.
67. Schneider HA, Lee JM, Olitsky PK (1957): Effect of nutrition on the production of acute disseminated encephalomyelitis in mice. J Exp Med 105:319-334.
68. Serreze DV, Prochazka M, Reifsnyder PC, Bridgett MM, Leiter EH (1994): Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J Exp Med 180:1553-1558.
69. Shaw MK, Kim C, Ho KL, Lisak RP, Tse HY (1992): A combination of adoptive transfer and antigenic challenge induces consistent murine experimental autoimmune encephalomyelitis in C57BL/6 mice and other reputed resistant strains. J Neuroimmunol 39:139-149.
70. Sobel RA, Blanchette BW, Bhan AK, Colvin RB (1984): The immunopathology of experimental allergic encephalomyelitis. I. Quantitative analysis of inflammatory cells in situ. J Immunol 132:2393-2401.
71. Stone SH (1961): Transfer of allergic encephalomyelitis by lymph node cells in inbred guinea pigs. Science 134:619-620.
72. Sudweeks JD, Wardell BB, Blackenhorn EP, Korngold R, Marini JC, Jodd JA, Livingstone KD, Frodsham MJ, Meeker ND, Lallatin N, Griffith JS, Minchek N, Teuscher C (1996): Multiple loci control susceptibility to actively-induced murine experimental allergic encephalomyelitis. In "Proceedings of the MS Forum Modern Management Workshop: Genetic factors in Multiple Sclerosis." Worthington, UK: PPS Europe Ltd.
73. Sundvall M, Jirholt J, Yang H-T, Jansson L, Engström Å, Pettersson U, Holmdahl R (1995): Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nature Genet 10:313-317.
74. Teitelbaum D, Lando Z, Arnon R (1978): Genetic control of susceptibility to experimental allergic encephalomyelitis - immunological studies. In Rose, Bigazzi, Warner (eds): "Genetic Control of Autoimmune Disease." Elsevier North Holland.
75. Todd JA, Aitman TJ, Cornall RJ, Ghosh S, Hall JR, Hearne CM, Knight AM, Love JM, McAleer MA, Prins JB, Rodrigues N, Lanthrop M, Pressey A, DeLarato NH, Peterson LB, Wicker LS (1991): Genetic analysis of autoimmune type I diabetes mellitus in mice. Nature 351:542-547.
76. Tsukada N, Koh C-S, Yanagisawa N, Okano A, Behan WMH, Behan PO (1987): A new model for multiple sclerosis: Chronic experimental allergic encephalomyelitis induced by immunization with cerebral endothelial cell membrane. Acta Neuropathol (Berl) 73:259-266.
77. Tuohy VK, Lu Z, Sobel RA, Laursen RA, Lees MB (1988a): A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis. J Immunol 141:1126-1130.
78. Tuohy VK, Sobel RA, Lees MB (1988b): Myelin proteolipid protein-induced experimental allergic encephalomyelitis. Variations of disease expression in different strains of mice. J Immunol 140: 1868-1873.
79. Tuohy VK, Lu Z, Sobel RA, Laursen RA, Lees MB (1989): Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol 142:1523-1527.
80. Urban JL, Kumar V, Kono DH, Gomez C, Horvath SJ, Clayton J, Ando DG, Sercarz EE, Hood L (1988): Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577-592.
81. Waxman FJ, Ferryman LE, Hinrichs DJ, Coe JE (1981): Genetic resistance to the induction of experimental allergic encephalomyelitis in Lewis rats. I. Genetic analysis of an apparent mutant strain with phenotypic resistance to experimental allergic encephalomyelitis. J Exp Med 153:61-74.
82. Wicker LS, Todd JA, Peterson LB (1995): Genetic control of autoimmune diabetes in the NOD mouse. Ann Rev Immunol 13:179-200.
83. Williams RM, Moore MJ (1973): Linkage of susceptibility to experimental allergic encephalomyelitis to the major histocompatibility locus in the rat. J Exp Med 138:775-783.
84. Yasuda T, Tsumita T, Nagai Y, Mitsuzawa E, Ohtani S (1975): Experimental allergic encephalomyelitis (EAE) in mice. I. Induction of EAE with mouse spinal cord homogenate and myelin basic protein. Jap J Exp Med 45:423-427.
85. Zamvil SS, Nelson PA, Mitchell DJ, Knobler RL, Fritz RB, Steinman L (1985): Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition. J Exp Med 162:2107-2124.